Indalo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Indalo Therapeutics's estimated annual revenue is currently $620k per year.
- Indalo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Indalo Therapeutics has 4 Employees.
- Indalo Therapeutics grew their employee count by 0% last year.
Indalo Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Research Scientist | Reveal Email/Phone |
Indalo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Indalo Therapeutics?
Indalo Therapeutics is a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). Our lead drug candidate, IDL-2965, began human clinical trials in early 2019. IDL-2965 provides potent antifibrotic efficacy at low once-daily oral doses across multiple animal models of disease in vital organ systems, including liver, lung, and kidney. Our innovative approach builds upon a solid foundation that includes: - A history of scientific and business achievement: Our R&D leadership team was responsible for the development and approval of Esbriet® for IPF at InterMune. - A legacy of deep target knowledge: Our founding scientists have decades of experience in the design, characterization, and development of integrin antagonists. - Marquee investors: Atlas Venture and F-Prime have an unparalleled track record of fostering innovation.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -56% | $20.4M |
#2 | $0.3M | 4 | N/A | N/A |
#3 | $0.1M | 4 | -33% | $26.5M |
#4 | $0.1M | 4 | 0% | $13.2M |
#5 | $0.3M | 4 | 33% | N/A |